General Information
Revision date
2013-05-22
Product name
AVASTIN(R) Vials (400 mg)
Product Synonyms
- AVASTIN(R) Vials (400 mg/16 ml)
1.2.1 Relevant identified uses
- formulated pharmaceutical active substance (antineoplastic)
Emergency telephone
US emergency phone: (800)-827-6243
Icons in SDS
Company Information
company name
Hoffmann-La Roche Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
Section 2
SECTION 2: Hazards identification
GHS Classification Emergency Overview Form aqueous solution sterile liquid Color colorless Hazard Overview - May cause allergic reactions. - May cause birth defects based on animal data.
Potential health effects
Exposure: Inhalation, Ingestion, Skin contact, Eye contact - Target Organs: Hematopoietic/blood system, Immune System - Acute Effects: May cause allergic reactions., This material is not likely to be significantly absorbed via occupational routes of entry due to its chemical structure and large molecular weight.
Potential chronic health
May cause blood system effects - Carcinogenicity: not listed by NTP, IARC or OSHA
2.1 Classification of the substance or mixture
no classification and labelling according to GHS
2.3 Other hazards
Additional Health Information - Conditions aggravated: Hypersensitivity to this material and other materials in its chemical class. - Reproductive toxicity: May cause birth defects. Since this material may effect the developing fetus, females planning to have a child and pregnant women should exercise caution regarding exposure. - It is also advisable for nursing mothers to exercise caution regarding exposure.
